Citigroup
PALI icon

Citigroup’s Palisade Bio PALI Stock Holding History

Citigroup’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$143K Sell
68,536
-19,168
-22% -$37.7K ﹤0.01% 4498
2026
Q1 		$153K Buy
87,704
+35,423
+68% +$64.4K ﹤0.01% 4111
2025
Q4 		$123K Buy
52,281
+49,934
+2,128% +$96K ﹤0.01% 4231
2025
Q3 		$2.02K Buy
+2,347
New +$1.83K ﹤0.01% 5479
2016
Q2 		– Hold
0
– – – 7323
2016
Q1 		– Hold
0
– – – 7677
2015
Q4 		– Hold
0
– – – 7272
2015
Q3 		– Hold
0
– – – 6925
2015
Q2 		– Hold
0
– -$7K – 7683
2015
Q1 		– Hold
0
– – – 6605
2014
Q4 		– Hold
0
– – – 5963
2014
Q3 		– Hold
0
– – – 6374
2014
Q2 		– Hold
0
– – – 6220
2014
Q1 		– Hold
0
– -$6K – 7156
2013
Q4 		– Hold
0
– – – 6577
2013
Q3 		– Hold
0
– – – 6931

Other funds holding PALI

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Citigroup's PALI Position: Q2 2026 in Review

Citigroup reduced its Palisade Bio (PALI) stake by 22% in Q2 2026, selling an estimated $37.7K and leaving 68,536 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #4498.

Citigroup first reported a position in PALI in Q3 2025 and has held it in 4 quarters since. The position peaked at $153K in Q1 2026. 124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

  • Citigroup held 68,536 shares of Palisade Bio worth $143K as of Q2 2026.
  • Citigroup sold 19,168 Palisade Bio shares in Q2 2026, an estimated $37.7K.
  • Palisade Bio made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #4498 holding.
  • Citigroup first reported a position in Palisade Bio in Q3 2025 and has held it in 4 quarters since.
  • Citigroup's Palisade Bio position peaked at $153K in Q1 2026.
  • 124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.